Who Needs Drug Prophylaxis against Malaria? My Personal View
Open Access
- 8 March 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 12 (4), 217-221
- https://doi.org/10.2310/7060.2005.12408
Abstract
A long tradition of successful malaria prophylaxis with chloroquine led to a dogma that drug prophylaxis should be given regardless of risk as soon as a traveler entered endemic areas. This prevailed also when resistance to chloroquine and adverse effects of alternatives became a problem. A cost/benefit analysis of the risk for malaria versus risk for adverse effects and cost of the recommended drug is not uniformly applied and drug prophylaxis is still advocated even when the risk for severe adverse effects greatly exceeds the risk for malaria, which is unethical.Keywords
This publication has 8 references indexed in Scilit:
- Malaria-Related Deaths among U.S. Travelers, 1963–2001Annals of Internal Medicine, 2004
- Malaria chemoprophylaxis: when should we use it and what are the options?Expert Review of Anti-infective Therapy, 2004
- Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm studyBMJ, 2003
- DEET: A Review and Update of Safety and Risk in the General PopulationJournal of Toxicology: Clinical Toxicology, 2003
- Phototoxic eruptions due to doxycycline-a dose-related phenomenonClinical and Experimental Dermatology, 1993
- Mortality from Plasmodium falciparum Malaria in Travelers from the United States, 1959 to 1987Annals of Internal Medicine, 1990
- Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.BMJ, 1987
- ACTIVITY OF A NEW ANTIMALARIAL AGENT, CHLOROQUINE (SN 7618)JAMA, 1946